These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9300735)

  • 21. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy].
    Röttinger EM
    Strahlenther Onkol; 1995 Apr; 171(4):247-8. PubMed ID: 7740416
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
    Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
    Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
    Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
    Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
    J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
    Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
    Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
    Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
    Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
    Massimino M; Cefalo G; Riva D; Biassoni V; Spreafico F; Pecori E; Poggi G; Collini P; Pollo B; Valentini L; Potepan P; Seregni E; Casanova M; Ferrari A; Luksch R; Polastri D; Terenziani M; Pallotti F; Clerici CA; Schiavello E; Simonetti F; Meazza C; Catania S; Podda M; Gandola L
    J Neurooncol; 2012 May; 108(1):163-71. PubMed ID: 22350379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
    J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.
    Mosijczuk AD; Nigro MA; Thomas PR; Burger PC; Krischer JP; Morantz RA; Kurdunowicz B; Mulne AF; Towbin RB; Freeman AI
    Cancer; 1993 Nov; 72(9):2755-62. PubMed ID: 8402500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
    Mynarek M; von Hoff K; Pietsch T; Ottensmeier H; Warmuth-Metz M; Bison B; Pfister S; Korshunov A; Sharma T; Jaeger N; Ryzhova M; Zheludkova O; Golanov A; Rushing EJ; Hasselblatt M; Koch A; Schüller U; von Deimling A; Sahm F; Sill M; Riemenschneider MJ; Dohmen H; Monoranu CM; Sommer C; Staszewski O; Mawrin C; Schittenhelm J; Brück W; Filipski K; Hartmann C; Meinhardt M; Pietschmann K; Haberler C; Slavc I; Gerber NU; Grotzer M; Benesch M; Schlegel PG; Deinlein F; von Bueren AO; Friedrich C; Juhnke BO; Obrecht D; Fleischhack G; Kwiecien R; Faldum A; Kortmann RD; Kool M; Rutkowski S
    J Clin Oncol; 2020 Jun; 38(18):2028-2040. PubMed ID: 32330099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.